THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 89 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,252,000 | +49.3% | 656,296 | 0.0% | 0.23% | +49.4% |
| Q3 2021 | $4,857,000 | -49.0% | 656,296 | 0.0% | 0.16% | -49.7% |
| Q2 2021 | $9,529,000 | +2.3% | 656,296 | +43.8% | 0.31% | -3.1% |
| Q1 2021 | $9,313,000 | +14.9% | 456,296 | 0.0% | 0.32% | +12.3% |
| Q4 2020 | $8,108,000 | +83.7% | 456,296 | +52.9% | 0.28% | +72.7% |
| Q3 2020 | $4,413,000 | -8.1% | 298,470 | +30.4% | 0.16% | -9.8% |
| Q2 2020 | $4,803,000 | -9.2% | 228,836 | 0.0% | 0.18% | -23.4% |
| Q1 2020 | $5,288,000 | +73.5% | 228,836 | +94.4% | 0.24% | +107.8% |
| Q4 2019 | $3,048,000 | +239.4% | 117,725 | +155.4% | 0.12% | +194.9% |
| Q3 2019 | $898,000 | +240.2% | 46,101 | +470.3% | 0.04% | +290.0% |
| Q3 2018 | $264,000 | +44.3% | 8,083 | 0.0% | 0.01% | +42.9% |
| Q2 2018 | $183,000 | -6.6% | 8,083 | 0.0% | 0.01% | -12.5% |
| Q1 2018 | $196,000 | – | 8,083 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |